Date: 2016-12-01
Type of information: Nomination
Compound:
Company: Kite Pharma (USA - CA)
Therapeutic area: Cancer - Oncology - Rare diseases
Type agreement: nomination
Action mechanism:
Disease:
Details: * On December 1, 2016, Kite Pharma announced the appointment of Jian Irish , Ph.D. as the company's Senior Vice President of Supply Chain. The appointment of Dr. Irish , who will be responsible for establishing and securing a reliable supply chain, including sourcing, logistics, inventory management, procurement, supply and operations planning process, further increases the depth of an industry-leading cell therapy Supply Chain organization. Dr. Irish will work closely with both the commercial and technical operations organization to create operational strategies for supply chain design, product life cycle management, launch and commercialization as the company prepares for the potential approval of Kite's lead product candidate, KTE-C19, by the FDA. Dr. Irish joins Kite from Sanofi, where she most recently served as the Vice President of Biologics Strategic Supply, Sourcing and Partnerships. She also served as Vice President of Biologics Product Development Technology Transfer at Sanofi. In these roles, Dr. Irish oversaw the strategy and execution of the Biologics supply chain and technical transfer processes to scale up Sanofi Biological operations. Prior to Sanofi, Dr. Irish was the Executive Director, General Manager of Japan Asia Pacific Supply Chain at Amgen as well as the Executive Director, Global Head of Contract Manufacturing where Dr. Irish made a critical impact in the commercialization of Vectibix®, Xgeva®, and Enbrel®. Dr. Irish holds a Bachelor of Science in Chemical Engineering from East China University of Science and Technology in Shanghai, China , a Master of Science and Ph.D. in Pharmaceutical Sciences from Chiba University in Chiba, Japan , and a Master of Business Administration from the Anderson School of Management at University of California, Los Angeles .
Financial terms:
Latest news:
